EVALUATION OF ANTIPSYCHOTIC DRUGS IN RELATION TO THEIR EFFECT ON METABOLIC RISK FACTORS

被引：0
|
作者：
Jindel, A. [1 ]
Yadav, D. [1 ]
Mishra, S. [1 ]
Sharma, P. [1 ]
机构：
[1] SMS Med Coll & Hosp, Dept Biochem, Jaipur 302004, Rajasthan, India
来源：
CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 2011年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：S384 / S384
页数：1
相关论文
共 50 条
  • [21] Increased metabolic risk in adolescents patients treated with atypical antipsychotic drugs: Preliminary results
    Cuerda Compes, C.
    Arango, C.
    Velasco, C.
    De Castro, M.
    Paron, L.
    Breton, I.
    Camblor, M.
    Garcia-Peris, P.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 497 - 497
  • [22] Metabolic disease and cardiovascular risk in psychiatric out-patients taking antipsychotic drugs
    Mackin, Paul
    Bishop, David
    Gallagher, Peter
    Watkinson, Helen M. O.
    Ferrier, Ian N.
    BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 166S - 166S
  • [23] Effect of antipsychotic drugs and orthostatic hypotension on the risk of falling in schizophrenic patients
    Ferinauli, Ferinauli
    Narulita, Sari
    Hijriyati, Yoanita
    JOURNAL OF PUBLIC HEALTH RESEARCH, 2021, 10 (02)
  • [24] Antipsychotic drugs and risk of QT prolongation
    Zaoui, S.
    Filali, H.
    Hakkou, F.
    El Karimi, S.
    Hattaoui, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 : 79 - 79
  • [25] Comparison of the metabolic syndrome risk factors in antipsychotic naive and chronic schizophrenia patients
    Robabeh, Soleimani
    Somayeh, Shokrgozar
    Masoomeh, Shekarriz-Fumani
    Melikad, Jalali Seyede
    ARCHIVES OF PSYCHIATRY AND PSYCHOTHERAPY, 2021, 23 (03): : 44 - 54
  • [26] Antipsychotic drugs, menstruation and osteoporosis risk
    Wong, J
    Seeman, M
    BIOLOGICAL PSYCHIATRY, 2002, 51 (08) : 175S - 175S
  • [27] Antipsychotic drugs and risk of pulmonary embolism
    Ettagmouti, Yassine
    Rochd, Mehdi
    Hamdani, Zeineb
    Habbal, Rachida
    ACTA CARDIOLOGICA, 2023, 78 : 50 - 50
  • [28] Antipsychotic drugs and the risk of venous thromboembolism
    Caspary, L.
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2011, 40 (03) : 173 - 176
  • [29] Increased adiposity and other risk factors for metabolic disturbances during antipsychotic treatment
    Newcomer, JW
    Haupt, D
    Breier, A
    Allison, D
    BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 2S - 2S
  • [30] Antipsychotic drugs and risk of pulmonary embolism
    Allenet, Benoit
    Schmidlin, Sophie
    Genty, Celine
    Bosson, Jean-Luc
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 (01) : 42 - 48
12345